Evidence mapPaperPMID 40005328Full record

ReviewMedicina (Kaunas, Lithuania)2025

Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation.

Maria-Alexandra Ciuca-Pană, Aristi Boulmpou, Cigdem Ileri, Giovanna Manzi, Michele Golino, Marina Ostojic, Akhmetzhan Galimzhanov, Stefan Busnatu, Simona Mega, Francesco Perone

Abstract readReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maria-Alexandra Ciuca-PanăCardiology Department, Carol Davila University of Medicine and Pharmacy, Bagdasar-Arseni Emergency Clinical Hospital, 041915 Bucharest, Romania.ORCID 0000-0001-8520-6478
Aristi BoulmpouThird Department of Cardiology, Aristotle University of Thessaloniki, Ippokratio General Hospital, 54636 Thessaloniki, Greece.ORCID 0000-0002-5008-114X
Cigdem IleriCardiology Department, LIV Hospital Vadi Istanbul, Istanbul 34396, Turkey.
Giovanna ManziDepartment of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Policlinico Universitario Umberto I, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-0676-3132
Michele GolinoPauley Heart Center, Virginia Commonwealth University, Richmond, VA 23284, USA.ORCID 0000-0003-0141-0127
Marina OstojicCardiology Clinic, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-2448-1799
Akhmetzhan GalimzhanovDepartment of the Propaedeutics of Internal Diseases, Semey Medical University, Semey 071400, Abai Region, Kazakhstan.ORCID 0000-0002-1605-9512
Stefan BusnatuCardiology Department, Carol Davila University of Medicine and Pharmacy, Bagdasar-Arseni Emergency Clinical Hospital, 041915 Bucharest, Romania.ORCID 0000-0002-4678-9655
Simona MegaDepartment of Cardiovascular Science, Campus Bio-Medico University of Rome, 00128 Rome, Italy.ORCID 0009-0009-0544-5651
Francesco PeroneCardiac Rehabilitation Unit, Rehabilitation Clinic "Villa delle Magnolie", Castel Morrone, 81020 Caserta, Italy.ORCID 0000-0002-1418-7908

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary artery disease is the leading cause of acute and chronic heart failure. Patients with heart failure and ischemic heart disease need a tailored assessment to define the appropriate treatment, while a specific multidisciplinary management plan should be followed. Indeed, several factors should be assessed before starting treatment, such as heart failure symptoms and/or signs, angina, electrocardiographic features, right and left ventricular systolic and diastolic function, serological abnormalities, cardiac structural and functional integrity, and pulmonary function. New scenarios and developments have emerged recently in this field, increasing our knowledge regarding pathophysiology, exercise, and pharmacology. Effective and appropriate management and treatment reduce the risk of death and hospitalization for heart failure. Herein, we provide an updated, state-of-the-art overview of pharmacological treatment and cardiac rehabilitation in patients with chronic heart failure and coronary artery disease. Furthermore, tailored and contemporary management in clinical practice will be proposed for this specific and fragile patient population.

Indexed as

Cardiac RehabilitationCoronary Artery DiseaseHeart FailureChronic DiseaseHumanscardiac rehabilitationchronic heart failurecoronary artery diseaseguideline-directed medical therapypharmacological treatment

Identifiers

PMID40005328
PMCPMC11857519

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.